Literature DB >> 18226917

Elevated levels of soluble ST2 protein in dengue virus infected patients.

Aniuska Becerra1, Rajas V Warke, Norma de Bosch, Alan L Rothman, Irene Bosch.   

Abstract

Levels of the soluble form of the interleukin-1 receptor-like 1 protein (IL-1RL-1/ST2) are elevated in the serum of patients with diseases characterized by an inflammatory response. The objective of this study was to determine the concentration of soluble ST2 (sST2) in dengue infected patients during the course of the disease. Twenty-four patients with confirmed dengue infection, classified as dengue fever, and 11 patients with other febrile illness (OFI) were evaluated. Levels of sST2 in serum and laboratory variables usually altered during dengue infections were measured. Dengue infected patients had higher serum sST2 levels than OFI at the end of the febrile stage and at defervescence (p=0.0088 and p=0.0004, respectively). Patients with secondary dengue infections had higher serum sST2 levels compared with patients with primary dengue infections (p=0.047 at last day of fever and p=0.030 at defervescence). Furthermore, in dengue infected patients, we found a significant negative correlation of sST2 with platelet and WBC counts, and positive correlation with thrombin time and transaminases activity. We suggest that sST2 could be a potential marker of dengue infection, could be associated with severity or could play a role in the immune response in secondary dengue virus infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18226917      PMCID: PMC2276732          DOI: 10.1016/j.cyto.2007.11.001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  56 in total

1.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.

Authors:  Daniel H Libraty; Timothy P Endy; Huo-Shu H Houng; Sharone Green; Siripen Kalayanarooj; Saroj Suntayakorn; Wanya Chansiriwongs; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

2.  Dengue immune response: low affinity, high febrility.

Authors:  Raymond M Welsh; Alan L Rothman
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

3.  Identification of human ST2 protein in the sera of patients with autoimmune diseases.

Authors:  K Kuroiwa; T Arai; H Okazaki; S Minota; S Tominaga
Journal:  Biochem Biophys Res Commun       Date:  2001-06-29       Impact factor: 3.575

4.  Mechanisms of hemorrhage in dengue without circulatory collapse.

Authors:  C Krishnamurti; S Kalayanarooj; M A Cutting; R A Peat; S W Rothwell; T J Reid; S Green; A Nisalak; T P Endy; D W Vaughn; S Nimmannitya; B L Innis
Journal:  Am J Trop Med Hyg       Date:  2001-12       Impact factor: 2.345

5.  ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation.

Authors:  Katsuhisa Oshikawa; Ken Yanagisawa; Shin ichi Tominaga; Yukihiko Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  2002-11-22       Impact factor: 3.575

6.  Expression and function of the ST2 gene in a murine model of allergic airway inflammation.

Authors:  K Oshikawa; K Yanagisawa; S Tominaga; Y Sugiyama
Journal:  Clin Exp Allergy       Date:  2002-10       Impact factor: 5.018

7.  MIP-1 alpha and MIP-1 beta induction by dengue virus.

Authors:  T A Spain-Santana; S Marglin; F A Ennis; A L Rothman
Journal:  J Med Virol       Date:  2001-10       Impact factor: 2.327

8.  Expression of ST2 in helper T lymphocytes of malignant pleural effusions.

Authors:  Katsuhisa Oshikawa; Ken Yanagisawa; Shoji Ohno; Shin-Ichi Tominaga; Yukihiko Sugiyama
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

9.  Identification of serum soluble ST2 receptor as a novel heart failure biomarker.

Authors:  Ellen O Weinberg; Masahisa Shimpo; Shelley Hurwitz; Shin-ichi Tominaga; Jean-Lucien Rouleau; Richard T Lee
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

10.  Recombinant ST2 boosts hepatic Th2 response in vivo.

Authors:  Aldo Amatucci; Tatiana Novobrantseva; Kevin Gilbride; Margot Brickelmaier; Paula Hochman; Alexander Ibraghimov
Journal:  J Leukoc Biol       Date:  2007-04-05       Impact factor: 4.962

View more
  28 in total

1.  Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B.

Authors:  Juan Wang; Yanjun Cai; Huifan Ji; Junyan Feng; Desalegn Admassu Ayana; Junqi Niu; Yanfang Jiang
Journal:  J Interferon Cytokine Res       Date:  2012-02-03       Impact factor: 2.607

Review 2.  IL-33/ST2 axis in inflammation and immunopathology.

Authors:  Marija Milovanovic; Vladislav Volarevic; Gordana Radosavljevic; Ivan Jovanovic; Nada Pejnovic; Nebojsa Arsenijevic; Miodrag L Lukic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice.

Authors:  H Yin; X Y Li; B H Yuan; B B Zhang; S L Hu; H B Gu; X B Jin; J Y Zhu
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

Review 4.  Interleukin-33 in health and disease.

Authors:  Foo Yew Liew; Jean-Philippe Girard; Heth Roderick Turnquist
Journal:  Nat Rev Immunol       Date:  2016-09-19       Impact factor: 53.106

5.  Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation.

Authors:  Joyce Y S Chow; Chun K Wong; Phyllis F Y Cheung; Christopher W K Lam
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

6.  Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.

Authors:  Isabel M Billiar; Jesse Guardado; Othman Abdul-Malak; Yoram Vodovotz; Timothy R Billiar; Rami A Namas
Journal:  J Surg Res       Date:  2019-07-03       Impact factor: 2.192

7.  Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study.

Authors:  Roberto Romero; Piya Chaemsaithong; Adi L Tarca; Steven J Korzeniewski; Eli Maymon; Percy Pacora; Bogdan Panaitescu; Noppadol Chaiyasit; Zhong Dong; Offer Erez; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-01

8.  Soluble ST2 plasma concentrations predict mortality in severe sepsis.

Authors:  Jacobien J Hoogerwerf; Michael W T Tanck; Marieke A D van Zoelen; Xavier Wittebole; Pierre-François Laterre; Tom van der Poll
Journal:  Intensive Care Med       Date:  2010-02-12       Impact factor: 17.440

9.  Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.

Authors:  Jozef Bartunek; Leen Delrue; Frederik Van Durme; Olivier Muller; Filip Casselman; Bart De Wiest; Romaric Croes; Sofie Verstreken; Marc Goethals; Herbert de Raedt; Jaydeep Sarma; Lija Joseph; Marc Vanderheyden; Ellen O Weinberg
Journal:  J Am Coll Cardiol       Date:  2008-12-16       Impact factor: 24.094

10.  Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function.

Authors:  Aniuska Becerra; Rajas V Warke; Kris Xhaja; Barbara Evans; James Evans; Katherine Martin; Norma de Bosch; Alan L Rothman; Irene Bosch
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.